Catechol-O-methyltransferase genotype and dopamine regulation in the human brain - PubMed (original) (raw)
Catechol-O-methyltransferase genotype and dopamine regulation in the human brain
Mayada Akil et al. J Neurosci. 2003.
Abstract
A functional polymorphism in the gene for catechol-O-methyltransferase (COMT) has been shown to affect executive cognition and the physiology of the prefrontal cortex in humans, probably by affecting prefrontal dopamine signaling. The COMT valine allele, associated with relatively poor prefrontal function, is also a gene that may increase risk for schizophrenia. Although poor performance on executive cognitive tasks and abnormal prefrontal function are characteristics of schizophrenia, so is psychosis, which has been related to excessive presynaptic dopamine activity in the striatum. Studies in animals have shown that diminished prefrontal dopamine neurotransmission leads to upregulation of striatal dopamine activity. We measured tyrosine hydroxylase (TH) mRNA in mesencephalic dopamine neurons in human brain and found that the COMT valine allele is also associated with increased TH gene expression, especially in neuronal populations that project to the striatum. This indicates that COMT genotype is a heritable aspect of dopamine regulation and it further explicates the mechanism by which the COMT valine allele increases susceptibility for psychosis.
Figures
Fig. 1.
Illustration of the sampling procedure. Red circles indicate an area of 1.76 mm2 sampled in each of the five cell groups selecting the region of highest density.
Fig. 2.
Autoradiograms of midbrain tissue sections after_in situ_ hybridization with radiolabeled riboprobes for TH (A, B) or DAT (C,D) mRNA in two matched cases with val/met (case 1193,A, C) or val/val (case 1111, B,D) genotypes, respectively. Scale bar, 1 mm
Fig. 3.
Comparisons of mean optical density, reflecting TH mRNA levels, between subjects with val/met (circles) and val/val (triangles) genotypes in the SNV. Each_symbol_ indicates the mean value for one male or female subject (open and filled symbols, respectively), and horizontal lines indicate group means.
Fig. 4.
Diagram illustrating elements of the circuitry and their putative involvement in the effects of COMT genotype on DA levels in prefrontal cortex and TH gene expression in the brainstem. Relative to val/met, the val/val genotype of the COMT enzyme leads to reduced DA levels in the PFC. It is speculated that indirect PFC projections via GABA neurons in the striatum or mesencephalon lead to increased gene expression of TH mRNA in DA cell groups projecting subcortically. The_question mark_ is to indicate that some of the GABA projections remain to be confirmed. Sources of anatomical information include the following: Lewis (1992), Deutch (1993),Murase et al. (1993), Williams and Goldman-Rakic (1995), Haber and Fudge (1997), Carr and Sesack (2000),Chiba et al. (2001), and Seamans et al. (2001).
Similar articles
- Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis.
McIntosh AM, Baig BJ, Hall J, Job D, Whalley HC, Lymer GK, Moorhead TW, Owens DG, Miller P, Porteous D, Lawrie SM, Johnstone EC. McIntosh AM, et al. Biol Psychiatry. 2007 May 15;61(10):1127-34. doi: 10.1016/j.biopsych.2006.05.020. Epub 2006 Oct 2. Biol Psychiatry. 2007. PMID: 17014827 - Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function.
Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM, Kleinman JE, Weinberger DR. Matsumoto M, et al. Neuroscience. 2003;116(1):127-37. doi: 10.1016/s0306-4522(02)00556-0. Neuroscience. 2003. PMID: 12535946 - Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.
Apud JA, Weinberger DR. Apud JA, et al. CNS Drugs. 2007;21(7):535-57. doi: 10.2165/00023210-200721070-00002. CNS Drugs. 2007. PMID: 17579498 Review. - Prefrontal neurons and the genetics of schizophrenia.
Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE. Weinberger DR, et al. Biol Psychiatry. 2001 Dec 1;50(11):825-44. doi: 10.1016/s0006-3223(01)01252-5. Biol Psychiatry. 2001. PMID: 11743939 Review.
Cited by
- Dopamine in Sports: A Narrative Review on the Genetic and Epigenetic Factors Shaping Personality and Athletic Performance.
Humińska-Lisowska K. Humińska-Lisowska K. Int J Mol Sci. 2024 Oct 29;25(21):11602. doi: 10.3390/ijms252111602. Int J Mol Sci. 2024. PMID: 39519153 Free PMC article. Review. - Interaction between catechol-O-methyltransferase Val/Met polymorphism and cognitive reserve for negative symptoms in schizophrenia.
Hou WP, Qin XQ, Hou WW, Han YY, Bo QJ, Dong F, Zhou FC, Li XB, Wang CY. Hou WP, et al. World J Psychiatry. 2024 May 19;14(5):695-703. doi: 10.5498/wjp.v14.i5.695. eCollection 2024 May 19. World J Psychiatry. 2024. PMID: 38808087 Free PMC article. - The Influence of Genetic Polymorphic Variability of the Catechol-O-methyltransferase Gene in a Group of Patients with a Diagnosis of Behavioural Addiction, including Personality Traits.
Recław R, Chmielowiec K, Suchanecka A, Boroń A, Chmielowiec J, Strońska-Pluta A, Kowalski MT, Masiak J, Trybek G, Grzywacz A. Recław R, et al. Genes (Basel). 2024 Feb 26;15(3):299. doi: 10.3390/genes15030299. Genes (Basel). 2024. PMID: 38540358 Free PMC article. - High-throughput computational investigation of protein electrostatics and cavity for SAM-dependent methyltransferases.
Jurich C, Yang ZJ. Jurich C, et al. Protein Sci. 2023 Jul;32(7):e4690. doi: 10.1002/pro.4690. Protein Sci. 2023. PMID: 37278582 Free PMC article. - Quantitative behavioral genetic and molecular genetic foundations of the approach and avoidance strategies.
Smederevac S, Sadiković S, Čolović P, Vučinić N, Milutinović A, Riemann R, Corr PJ, Prinz M, Budimlija Z. Smederevac S, et al. Curr Psychol. 2022 Jan 25:1-15. doi: 10.1007/s12144-022-02724-9. Online ahead of print. Curr Psychol. 2022. PMID: 35095249 Free PMC article.
References
- Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry. 1998;155:761–767. - PubMed
- Akil M, Pierri J, Whitehead R, Edgar C, Mohila C, Sampson A, Lewis D. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry. 1999;156:1580–1589. - PubMed
- Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A, III, Noll DC, Cohen JD. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry. 2001;58:280–288. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous